Literature DB >> 21292884

Drug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malaria.

Bethany L Hedt1, Miriam K Laufer, Ted Cohen.   

Abstract

In resource-constrained environments, monitoring the occurrence of tuberculosis (TB), human immunodeficiency virus (HIV), or malaria resistant to the limited number of available drugs is essential for national treatment program success. Countries with limited resources and technical capacity rely on survey designs and methods that are simple and easily integrated into routine clinical activities to minimize the impact on overburdened clinics. This paper reviews the most commonly used methods for drug-resistance surveillance of TB, HIV, and malaria and discusses the strengths and limitations of these different strategies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292884      PMCID: PMC3029167          DOI: 10.4269/ajtmh.2011.10-0363

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  28 in total

1.  Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda.

Authors:  N Ndembi; F Lyagoba; B Nanteza; G Kushemererwa; J Serwanga; E Katongole-Mbidde; H Grosskurth; P Kaleebu
Journal:  AIDS Res Hum Retroviruses       Date:  2008-06       Impact factor: 2.205

2.  Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection.

Authors:  Troels Lillebaek; Asger Dirksen; Inga Baess; Benedicte Strunge; Vibeke Ø Thomsen; Ase B Andersen
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

3.  HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.

Authors:  Hien Tran Nguyen; Nguyen Bui Duc; Ritu Shrivastava; Tram Hong Tran; Tuan Anh Nguyen; Pham Hang Thang; Janet M McNicholl; Wanna Leelawiwat; Wannee Chonwattana; Kassim Sidibe; Masami Fujita; Chau Minh T Luu; Reshma Kakkar; Diane E Bennett; Jonathan Kaplan; Lisa Cosimi; Mitchell I Wolfe
Journal:  Antivir Ther       Date:  2008

4.  Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia.

Authors:  Woldaregay Erku Abegaz; Zehava Grossman; Dawit Wolday; Daniela Ram; Jonathan Kaplan; Kassim Sibide; Tadesse Wuhib; Shabbir Ismael; John Nkengasong; Teferi Mekonen; Hiwot Berhanu; Tsehaynesh Messele; Sileshi Lulseged; Shlomo Maayan; Yohannes Mengistu
Journal:  Antivir Ther       Date:  2008

5.  World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.

Authors:  Michael R Jordan; Diane E Bennett; Silvia Bertagnolio; Charles F Gilks; Donald Sutherland
Journal:  Antivir Ther       Date:  2008

6.  Surveillance of HIV type 1 drug resistance among naive patients from Venezuela.

Authors:  Julio Castillo; Mario Comegna; Wilmary Quijada; Valérie Jauvin; Patricia Pinson; Bernard Masquelier; Hervé Fleury; Erika Castro
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

7.  Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.

Authors:  Diane E Bennett; Ricardo J Camacho; Dan Otelea; Daniel R Kuritzkes; Hervé Fleury; Mark Kiuchi; Walid Heneine; Rami Kantor; Michael R Jordan; Jonathan M Schapiro; Anne-Mieke Vandamme; Paul Sandstrom; Charles A B Boucher; David van de Vijver; Soo-Yon Rhee; Tommy F Liu; Deenan Pillay; Robert W Shafer
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

8.  Estimating the magnitude and direction of bias in tuberculosis drug resistance surveys conducted only in the public sector: a simulation study.

Authors:  Ted Cohen; Bethany L Hedt; Marcello Pagano
Journal:  BMC Public Health       Date:  2010-06-21       Impact factor: 3.295

Review 9.  Monitoring and deterring drug-resistant malaria in the era of combination therapy.

Authors:  Miriam K Laufer; Abdoulaye A Djimdé; Christopher V Plowe
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

10.  Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.

Authors:  Visva Pillay; Johanna Ledwaba; Gillian Hunt; Mpho Rakgotho; Beverly Singh; Lindiwe Makubalo; Diane E Bennett; Adrian Puren; Lynn Morris
Journal:  Antivir Ther       Date:  2008
View more
  7 in total

1.  Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling.

Authors:  Bethany Lynn Hedt; Frank van Leth; Matteo Zignol; Frank Cobelens; Wayne van Gemert; Nguyen Viet Nhung; Svitlana Lyepshina; Saidi Egwaga; Ted Cohen
Journal:  Epidemiology       Date:  2012-03       Impact factor: 4.822

2.  Pharmacokinetics of sequential doses of capreomycin powder for inhalation in guinea pigs.

Authors:  L Garcia-Contreras; Pavan Muttil; John K Fallon; Mohan Kabadi; Robert Gerety; Anthony J Hickey
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

3.  Drying anti-malarial drugs in vitro tests to outsource SYBR green assays.

Authors:  Karim Traore; Adeline Lavoignat; Guillaume Bonnot; Fatimata Sow; Giuliana C Bess; Marjorie Chavant; Frederick Gay; Ogobara Doumbo; Stephane Picot
Journal:  Malar J       Date:  2015-02-21       Impact factor: 2.979

Review 4.  An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000.

Authors:  Elizabeth A Ashley; Judith Recht; Arlene Chua; David Dance; Mehul Dhorda; Nigel V Thomas; Nisha Ranganathan; Paul Turner; Philippe J Guerin; Nicholas J White; Nicholas P Day
Journal:  J Antimicrob Chemother       Date:  2018-07-01       Impact factor: 5.790

5.  Molecular assays for antimalarial drug resistance surveillance: A target product profile.

Authors:  Christian Nsanzabana; Frederic Ariey; Hans-Peter Beck; Xavier C Ding; Edwin Kamau; Sanjeev Krishna; Eric Legrand; Naomi Lucchi; Olivo Miotto; Sidsel Nag; Harald Noedl; Cally Roper; Philip J Rosenthal; Henk D F H Schallig; Steve M Taylor; Sarah K Volkman; Iveth J Gonzalez
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

Review 6.  Transmitted Drug Resistance in Antiretroviral Therapy-Naive Persons With Acute/Early/Primary HIV Infection: A Systematic Review and Meta-Analysis.

Authors:  Chunxiang Guo; Yaxin Wu; Yang Zhang; Xinchao Liu; Aixin Li; Meixia Gao; Tong Zhang; Hao Wu; Guanzhi Chen; Xiaojie Huang
Journal:  Front Pharmacol       Date:  2021-11-24       Impact factor: 5.810

7.  Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.

Authors:  Joseph Fokam; Serge C Billong; Anne C Z K Bissek; Etienne Kembou; Pascal Milenge; Ibile Abessouguie; Armand S Nkwescheu; Zephirin Tsomo; Avelin F Aghokeng; Grace D Ngute; Peter M Ndumbe; Vittorio Colizzi; Jean B N Elat
Journal:  BMC Public Health       Date:  2013-04-08       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.